Category: Finance
Long Shortz with Mithril Resources: The silver lining of silver mining in Mexico
Stockhead’s Sarah Hughan sits down with Mithril Resources (ASX:MTH) managing director and CEO John Skeet to get the short end of the long story on the [more…]
ASX Small Caps Lunch Wrap: Whose bark could be worse than their flight this week?
Local markets have fallen again on Friday morning, with pretty much every sector in the brace position (face down, arse up) as the ASX hurtles [more…]
Rock Yarns: Why Altech Batteries is going the distance on long duration energy
Stock analysis veteran and lover of the resources game, Peter Strachan, is back for another instalment of the Rock Yarns podcast. In this episode, Peter [more…]
Resources Top 4: Bubalus kicks off maiden REE drilling in NT; SER still surging on strategic gains
Bubalus green lit to spin the drills at its Nolans East REE project in the NT Paterson Resources flogs $2.85m worth of its Burraga copper-gold [more…]
Long Shortz with RareX: Staking fertile ground for fantastic niobium find
Stockhead’s Sarah Hughan sits down with RareX (ASX:REE) CEO James Durrant to get the short end of the long story on the company’s latest news. The [more…]
Riversgold is prodding a juicy porphyry on its way to carve out a maiden gold resource at Northern Zone
AC drilling campaign underway at Riversgold’s Northern Zone gold project Northern Zone has an exploration target of 200-250Mt for 2.5-4.8Moz gold Step-out drilling to follow [more…]
Maiden drilling at New Age Exploration’s Quartz Hill shows the way to lithium treasures
Assay results from RC Drilling at the Quartz Hill project have confirmed lithium anomalism at depth NAE is targeting LCT Pegmatites similar to other Central [more…]
ASX Health Stocks: FDA gives nod to PYC, and Althea’s new JV puts cannabis drinks in US bottle shops
PYC Therapeutics gets FDA approval PYC Therapeutics (ASX:PYC) has received an Orphan Drug Designation (ODD) from the US FDA for its drug candidate, PYC-001, aimed [more…]
Top 10 at 10: This is what happens when AstraZeneca selects your tech for a clinical trial
Stockhead’s Top 10 at 10, published at ~10.40am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. [more…]
Market Highlights: ASX in for a bumpy day; Boeing hits turbulence and SpaceX valued at US$200B
ASX 200 set for losses on US market woes and Fed uncertainty Nvidia soars while Boeing falters; Live Nation hit by antitrust worries SpaceX eyes [more…]
